T 1966/16 (HDAC Modulators / GLAXOSMITHKLINE) of 20.01.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T196616.20200120
- Date of decision
- 20 January 2020
- Case number
- T 1966/16
- Petition for review of
- -
- Application number
- 09714148.5
- IPC class
- A61K 47/48
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- INTRACELLULAR ENZYME AND RECEPTOR MODULATION
- Applicant name
- GlaxoSmithKline Intellectual Property Development
Limited - Opponent name
- -
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1) (2007)European Patent Convention Art 56 (2007)Rules of procedure of the Boards of Appeal Art 11 (2020)Rules of procedure of the Boards of Appeal Art 12(2) (2020)
- Keywords
- Inventive step - (yes)
Remittal to the department of first instance - special reasons for remitting the case - Catchword
- -
- Cited cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division for further prosecution.